Compare ATRA & AUBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATRA | AUBN |
|---|---|---|
| Founded | 2012 | 1907 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 94.2M | 92.5M |
| IPO Year | 2014 | 1996 |
| Metric | ATRA | AUBN |
|---|---|---|
| Price | $9.45 | $26.62 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $13.67 | N/A |
| AVG Volume (30 Days) | ★ 36.6K | 2.2K |
| Earning Date | 11-11-2026 | 10-26-2026 |
| Dividend Yield | N/A | ★ 4.06% |
| EPS Growth | ★ 122.52 | 13.66 |
| EPS | N/A | ★ 1.29 |
| Revenue | ★ $120,772,000.00 | $619,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,334.59 | N/A |
| P/E Ratio | ★ N/A | $20.64 |
| Revenue Growth | N/A | ★ 0.81 |
| 52 Week Low | $3.92 | $21.01 |
| 52 Week High | $19.15 | $28.88 |
| Indicator | ATRA | AUBN |
|---|---|---|
| Relative Strength Index (RSI) | 52.74 | 50.27 |
| Support Level | $8.96 | $26.25 |
| Resistance Level | $11.22 | $26.83 |
| Average True Range (ATR) | 0.67 | 0.48 |
| MACD | 0.06 | -0.03 |
| Stochastic Oscillator | 79.08 | 18.69 |
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.
Auburn National Bancorp Inc is a bank holding company registered with the Board of Governors of the Federal Reserve System (the Federal Reserve). As a bank holding company, the Company may diversify into a broader range of financial services and other business activities than are currently permitted to the Bank under applicable laws and regulations. The holding company structure also provides greater financial and operating flexibility than is presently permitted to the Bank. The Company's business is conducted through the Bank and its subsidiaries. Although it has no immediate plansto conduct any other business, the Company may engage directly or indirectly in several activities closely related to banking permitted by the Federal Reserve.